BRAMANT Trademark

Trademark Overview


On Tuesday, January 21, 2020, a trademark application was filed for BRAMANT with the United States Patent and Trademark Office. The USPTO has given the BRAMANT trademark a serial number of 88767132. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Friday, October 8, 2021. This trademark is owned by Pfizer Inc.. The BRAMANT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
bramant

General Information


Serial Number88767132
Word MarkBRAMANT
Filing DateTuesday, January 21, 2020
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateFriday, October 8, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 19, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateFriday, October 8, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Friday, October 8, 2021ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Friday, October 8, 2021ABANDONMENT - AFTER PUBLICATION
Thursday, October 7, 2021TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, June 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 28, 2021EXTENSION 2 GRANTED
Friday, May 28, 2021EXTENSION 2 FILED
Friday, May 28, 2021TEAS EXTENSION RECEIVED
Saturday, December 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 3, 2020EXTENSION 1 GRANTED
Thursday, December 3, 2020EXTENSION 1 FILED
Thursday, December 3, 2020TEAS EXTENSION RECEIVED
Tuesday, July 14, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 19, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 19, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 9, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 9, 2020ASSIGNED TO EXAMINER
Saturday, January 25, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 24, 2020NEW APPLICATION ENTERED IN TRAM